Vision disorder

New Healthcare & Life Sciences Communications Firm, ReadHealthy Communications, Announces Company Launch

Retrieved on: 
Monday, October 9, 2023
Ophthalmology, Health, Corporate title, MS, Human, Boston University, Kendall Hunt Publishing Company, Communication, Empathy, Cardiology, Neurology, Writing, Health communication, Medication, Data, Mental health, Vision disorder, Richard Roberts (pharmaceutical executive), Marketing, Publication, Optic nerve hypoplasia, William Paterson University, Racism, Disability, PR, Journalism, Patient, Management, Science

LIVINGSTON,N.J., Oct. 9, 2023 /PRNewswire-PRWeb/ -- Jennifer Ringler, the firm's founder & CEO, is a former journalist and member of the blind and visually impaired community –

Key Points: 
  • ReadHealthy Communications' founder & CEO, Jennifer Ringler, MS, is an experienced healthcare communicator and former journalist who was born with a rare vision disorder, optic nerve hypoplasia.
  • ReadHealthy Communications, a public relations, marketing, and corporate communications firm serving clients in pharma, biotech, med tech, health tech, and other areas of healthcare, announced today its official company launch.
  • "I learned so much and helped tell so many important stories in healthcare while working at other communications and PR agencies for the past decade," said Jennifer Ringler, MS, ReadHealthy Communications' founder & CEO.
  • Jennifer has been published in Pharmaceutical Executive, Life Science Leader, Chief Healthcare Executive, PRNews, and many other industry blogs and publications.

Clear vision for the future: Canadian Ophthalmological Society celebrates Indigenous Children Eye Examination Project, impacting 6,000 lives to date

Retrieved on: 
Tuesday, August 8, 2023
Retina, Vision disorder, Fort Albany, Eye Health UK, Travel, Strabismus, ICEE, DSM-IV codes, Kashechewan First Nation, Weenusk First Nation, Eye, Ptosis, Light, Cataract, Refractive error, Attawapiskat First Nation, System, Fort Albany First Nation, Approximation error, Radar, COS, Growth, Moose Cree First Nation, Ageing, Amblyopia, American Ophthalmological Society, Toy, Telescopic sight, Indigenous

This model is designed to benefit Indigenous children in underserved areas of Canada and involves training local youth to assess children for eye problems.

Key Points: 
  • This model is designed to benefit Indigenous children in underserved areas of Canada and involves training local youth to assess children for eye problems.
  • "Many children in these Indigenous communities have to travel over one hour by plane to see an eye care professional.
  • It is critical to develop a national vision screening strategy to prevent long-lasting vision loss, especially in children.
  • ICEE aims to become the national outreach program for delivering eye care to Indigenous children living in the remote and under-served parts of Canada."

STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems

Retrieved on: 
Wednesday, August 10, 2022
Other Consumer, Women, Parenting, Men, Pharmaceutical, Optical, TV and Radio, Family, Music, Medical Devices, Consumer, LGBTQ+, Entertainment, Film & Motion Pictures, Surgery, Health, Advertising, Communications, Celebrity, U.S. Securities and Exchange Commission, Lens (anatomy), CEO, Dioptre, Dry eye syndrome, Prevalence, Security (finance), Marketing, Education, STAAR, Ophthalmology, Night vision, Marriage, MD, Jonas, Iris, Glaucoma, Astigmatism, Multimedia, Lens, Retinal implant, EVO, American Society of Cataract and Refractive Surgery, Inflammation, Technology, Perseverance, Partnership, Refractive surgery, Cornea, Literature, Myopia, Intraocular lens, ICL, Awareness, Nave, Social media, Goal, FDA, Quality, Cataract, Hans Hassle, Society, Review, Eye, Glasses, NASDAQ, Intention, Vision disorder, Nursing, ASCRS, Telescopic sight, Medical device, Borosilicate glass, Life, LASIK, Patient

Joe Jonas had myopia since childhood, which is also known as nearsightedness or the need for distance vision correction.

Key Points: 
  • Joe Jonas had myopia since childhood, which is also known as nearsightedness or the need for distance vision correction.
  • He decided to undergo the EVO procedure, which involved adding a small, flexible lens in both eyes to correct his distance vision.
  • Joe Jonas was a great candidate for EVO and we are thrilled to have helped him achieve his vision goals.
  • Joe Jonas needed EVO lenses below -5.0 diopters, so he was a great candidate for EVO, said Scott D. Barnes, MD, Chief Medical Officer of STAAR Surgical.

Dr. Scott Perkins at Barnet Dulaney Perkins Eye Center is first in the Southwest US to implant the EVO Visian ICL, an Innovative Solution to Myopia and Astigmatism

Retrieved on: 
Tuesday, April 12, 2022
Vision disorder, Patient, CEO, Cornea, Intraocular lens, Packer, Ophthalmology, ICL, AVP, Population, Eye, EVO, Astigmatism, Lens (anatomy), Life, Retina, Review, STAAR, Literature, Company, Glaucoma, Technology, Maintenance, FDA, Prevalence, Lens, Telescopic sight, Medical device, Hospital, PHOENIX, Myopia

PHOENIX, April 12, 2022 /PRNewswire-PRWeb/ -- Today, Dr. Scott Perkins of Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, became the first surgeon in the Southwest to implant a new solution for the correction of myopia and myopia with astigmatism: EVO Visian ICL.

Key Points: 
  • Today, Dr. Scott Perkins of Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, became the first surgeon in the Southwest to implant a new solution for the correction of myopia and myopia with astigmatism: EVO Visian ICL.
  • PHOENIX, April 12, 2022 /PRNewswire-PRWeb/ -- Today, Dr. Scott Perkins of Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, became the first surgeon in the Southwest to implant a new solution for the correction of myopia and myopia with astigmatism: EVO Visian ICL.
  • (3)
    Dr. Scott Perkins, surgeon and founding partner at Barnet Dulaney Perkins Eye Center in Arizona, took part in the FDA clinical trials for the EVO Visian ICL.
  • He was the first surgeon in the Southwest United States to implant the innovative solution to correct myopia and myopia with astigmatism.

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

Retrieved on: 
Monday, March 28, 2022
FDA, Surgery, Medical Devices, Health, Optical, Nave, Cataract, Refractive surgery, Lens (anatomy), CEO, Animation, MD, Lens, Intention, Iris, Regulation of tobacco by the U.S. Food and Drug Administration, EVO, Breast implant, Security (finance), Glasses, Population, Literature, Marketing, ASCRS, Quality, Vision disorder, ACD, Quality of life, Cornea, Surgeon, U.S. Securities and Exchange Commission, ICL, Packer, American Society of Cataract and Refractive Surgery, NASDAQ, STAAR, Intraocular lens, Clinical trial, Multimedia, Review, Inflammation, Society, COVID, FDA, Company, City, Ophthalmology, Glaucoma, Astigmatism, Nursing, Food, PIB, Endothelium, Prevalence, Safety, Public relations, COVID-19, Eye, Maintenance, Video, Medical device, Myopia, Life, Patient, LASIK

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism.
  • STAARs Implantable Collamer lenses have been improving vision in patients for more than 20 years globally.
  • STAARs lens used in refractive surgery is called an Implantable Collamer Lens or ICL, which includes the EVO Visian ICL product line.
  • Since implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications.

Prevent Blindness Declares 2022 as the "Year of Children's Vision"

Retrieved on: 
Wednesday, December 15, 2021
Instagram, LinkedIn, Research to Prevent Blindness, Vision disorder, Health equity, Education, Child, Awareness, Learning, Public health, Social media, Lists of diseases, Myopia, Astigmatism, National Center for Healthy Housing, Caregiver, Common, CEO, Research, Far-sightedness, Severe cognitive impairment, Quality of life, Visual impairment, Eye, Amblyopia, Strabismus, Twitter, YouTube, Health, Health insurance, Toy, Pharmaceutical industry, Facebook, Vision

CHICAGO, Dec. 15, 2021 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's oldest nonprofit eye health and safety organization, has declared 2022 the "Year of Children's Vision."

Key Points: 
  • CHICAGO, Dec. 15, 2021 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's oldest nonprofit eye health and safety organization, has declared 2022 the "Year of Children's Vision."
  • For information on partnering or sponsorship opportunities for the Year of Children's Vision, please contact Kate Desulis, Prevent Blindness Director of Development, at [email protected] .
  • Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.
  • Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America.

NCCVEH at Prevent Blindness and the National Head Start Association Launch New Online Resource to Educate Public on Importance of Good Vision

Retrieved on: 
Tuesday, October 20, 2020
Medical specialties, Ophthalmology, Optometry, Visual impairment, Visual perception, Vision disorder, Medicine, Optometric Extension Program

At least one in five children enrolled in Head Start has an uncorrected vision disorder.

Key Points: 
  • At least one in five children enrolled in Head Start has an uncorrected vision disorder.
  • The Small Steps for Big Vision resource was approved by a select group of volunteers from the ophthalmology, optometry, non-profit and public health fields.
  • Head Start programs that conducted pilot testing of the Small Steps for Big Vision resource include:
    5.
  • Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.

NovaSight and Tobii Demonstrate Solution for Treating Amblyopia - the Leading Cause of Vision Loss in Children

Retrieved on: 
Tuesday, January 7, 2020
RTT, Senses, Perception, Amblyopia, Vision, Tobii Technology, Vision disorder, Lazy eye, Visual impairment, Ophthalmology

The revolutionary solution combines advanced eye tracking and sophisticated artificial intelligence to treat amblyopia, a vision disorder commonly known as lazy eye, which is the leading cause of vision loss in children.

Key Points: 
  • The revolutionary solution combines advanced eye tracking and sophisticated artificial intelligence to treat amblyopia, a vision disorder commonly known as lazy eye, which is the leading cause of vision loss in children.
  • "Such is the case with the NovaSight CureSightsolution we are demonstrating at CES, which represents an important new approach to treating a serious vision disorder that impactsmany children and families."
  • "There are 10 million amblyopia patients in the United States alone, and tens of millions worldwide," said Ran Yam, CEO, NovaSight.
  • To learn more about how Tobii eye tracking is an engine for innovation, read our blog here .

NovaSight and Tobii Demonstrate Solution for Treating Amblyopia - the Leading Cause of Vision Loss in Children

Retrieved on: 
Tuesday, January 7, 2020
RTT, Senses, Perception, Amblyopia, Vision, Tobii Technology, Vision disorder, Lazy eye, Visual impairment, Ophthalmology

The revolutionary solution combines advanced eye tracking and sophisticated artificial intelligence to treat amblyopia, a vision disorder commonly known as lazy eye, which is the leading cause of vision loss in children.

Key Points: 
  • The revolutionary solution combines advanced eye tracking and sophisticated artificial intelligence to treat amblyopia, a vision disorder commonly known as lazy eye, which is the leading cause of vision loss in children.
  • "Such is the case with the NovaSight CureSightsolution we are demonstrating at CES, which represents an important new approach to treating a serious vision disorder that impactsmany children and families."
  • "There are 10 million amblyopia patients in the United States alone, and tens of millions worldwide," said Ran Yam, CEO, NovaSight.
  • To learn more about how Tobii eye tracking is an engine for innovation, read our blog here .